Tracking of Therapeutic Stem Cells Reveals No Cancer Risk
April 11, 2016
(Medical News Today) – Producing therapeutic stem cells does not lead to genetic changes related to cancer, according to research published in PLoS Genetics. This is encouraging news for those investigating the use of induced pluripotent stem (iPS) cells in the field of regenerative medicine. Pluripotent cells are stem cells that can generate all of the different cell types in the body.